Cargando…

An integrated bioinformatical analysis of miR-19a target genes in multiple myeloma

MicroRNA (miR)-19a, as an oncomiR, has been studied in several types of cancer; however, its role in the development and progression of multiple myeloma (MM) remains unclear. The present study used a bioinformatics approach to investigate the involvement of miR-19a in MM. miR-19a targets were predic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Hongyan, Wu, Xianda, Ma, Guiru, Sun, Lixia, Meng, Jianbo, Song, Xiaoning, Zhang, Jinqiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704339/ https://www.ncbi.nlm.nih.gov/pubmed/29201171 http://dx.doi.org/10.3892/etm.2017.5173

Ejemplares similares

An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma
por: Ronchetti, Domenica, et al.
Publicado: (2008)

An integrated bioinformatics analysis to investigate the targets of miR-133a-1 in breast cancer
por: Meng, Yanchun, et al.
Publicado: (2021)

Epigenetic silencing of LPP/miR-28 in multiple myeloma
por: Li, Zhenhai, et al.
Publicado: (2018)

The expression and role of miR-181a in multiple myeloma
por: Yuan, Ruili, et al.
Publicado: (2018)

An Integrated Bioinformatics Analysis of the Potential Regulatory Effects of miR-21 on T-cell Related Target Genes in Multiple Sclerosis
por: Manian, Mostafa, et al.
Publicado: (2021)

miR-29b: A new demethylator in multiple myeloma
por: Benetatos, Leonidas
Publicado: (2013)

Circulating miR-451a levels as a potential biomarker to predict the prognosis of patients with multiple myeloma
por: Zhong, Ling, et al.
Publicado: (2020)

Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine
por: Luo, Xiaochuang, et al.
Publicado: (2014)

miR-19a-3p Functions as an Oncogene by Regulating FBXO32 Expression in Multiple Myeloma
por: Li, Ying, et al.
Publicado: (2021)

New role of hypoxia in pathophysiology of multiple myeloma through miR-210
por: Saba, Fakhredin, et al.
Publicado: (2018)

The mechanism study of miR‐125b in occurrence and progression of multiple myeloma
por: Gao, Da, et al.
Publicado: (2017)

miR-22 suppresses DNA ligase III addiction in multiple myeloma
por: Caracciolo, Daniele, et al.
Publicado: (2018)

miR-140-5p inhibits the proliferation of multiple myeloma cells by targeting VEGFA
por: Liu, Min, et al.
Publicado: (2021)

Integrated Bioinformatics Analysis Confirms the Diagnostic Value of Nourin-Dependent miR-137 and miR-106b in Unstable Angina Patients
por: Elgebaly, Salwa A., et al.
Publicado: (2023)

Bioinformatics and Expression Analyses of miR-639, miR-641, miR-1915-3p and miR-3613-3p in Colorectal Cancer Pathogenesis
por: Avsar, Rusen, et al.
Publicado: (2023)

Long Noncoding RNA CRNDE Promotes Multiple Myeloma Cell Growth by Suppressing miR-451
por: Meng, Yi-Bin, et al.
Publicado: (2017)

MiR-181a functions as an oncogene by regulating CCND1 in multiple myeloma
por: Yan, Xiao, et al.
Publicado: (2020)

miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma
por: Caracciolo, Daniele, et al.
Publicado: (2021)

Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p
por: Liu, Haiyan, et al.
Publicado: (2019)

The Effect of miR-361-3p Targeting TRAF6 on Apoptosis of Multiple Myeloma Cells
por: Fan, Zhen, et al.
Publicado: (2021)

miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma
por: Misso, Gabriella, et al.
Publicado: (2019)

The clinical value of lncRNA MALAT1 and its targets miR‐125b, miR‐133, miR‐146a, and miR‐203 for predicting disease progression in chronic obstructive pulmonary disease patients
por: Liu, Shuang, et al.
Publicado: (2020)

Bioinformatics analysis of the common targets of miR-223-3p, miR-122-5p, and miR-93-5p in polycystic ovarian syndrome
por: Zou, Liping, et al.
Publicado: (2023)

Multiple Myeloma-Derived Exosomes Regulate the Functions of Mesenchymal Stem Cells Partially via Modulating miR-21 and miR-146a
por: Cheng, Qian, et al.
Publicado: (2017)

miR-451a suppression of IL-6R can inhibit proliferation and increase apoptosis through the JAK2/STAT3 pathway in multiple myeloma
por: Zhong, Ling, et al.
Publicado: (2020)

In Vitro and in Vivo Anti-tumor Activity of miR-221/222 Inhibitors in Multiple Myeloma
por: Di Martino, Maria Teresa, et al.
Publicado: (2013)

Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma
por: Cosco, Donato, et al.
Publicado: (2015)

Evidence of novel miR-34a-based therapeutic approaches for multiple myeloma treatment
por: Zarone, Mayra Rachele, et al.
Publicado: (2017)

Epigenetic silencing of miR-340-5p in multiple myeloma: mechanisms and prognostic impact
por: Li, Zhenhai, et al.
Publicado: (2019)

Synthetic miR-145 mimic inhibits multiple myeloma cell growth in vitro and in vivo
por: Zhang, Qi, et al.
Publicado: (2021)

Identification of key candidate genes and pathways in multiple myeloma by integrated bioinformatics analysis
por: Yan, Haimeng, et al.
Publicado: (2019)

Circ_0007841 promotes the progression of multiple myeloma through targeting miR-338-3p/BRD4 signaling cascade
por: Wang, Yan, et al.
Publicado: (2020)

Bioinformatic Identification of miR-622 Key Target Genes and Experimental Validation of the miR-622-RNF8 Axis in Breast Cancer
por: Liu, Chuanyang, et al.
Publicado: (2019)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma
por: Amodio, Nicola, et al.
Publicado: (2012)

Gambogenic Acid Exerts Antitumor Activity in Hypoxic Multiple Myeloma Cells by Regulation of miR-21
por: Liu, Ping, et al.
Publicado: (2017)

Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma
por: Stamato, Maria Angelica, et al.
Publicado: (2017)

Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma
por: Amodio, Nicola, et al.
Publicado: (2019)

Increased expression of miR-27 predicts poor prognosis and promotes tumorigenesis in human multiple myeloma
por: Che, Feifei, et al.
Publicado: (2019)

The miR-125a and miR-320c are potential tumor suppressor microRNAs epigenetically silenced by the polycomb repressive complex 2 in multiple myeloma
por: Alzrigat, Mohammad, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uiuv42jbs7h38r62cqreqhja8d